News from around the community includes items from Lemont, Elmwood Park, Franklin Park, Oak Park, River Forest, Elmhurst and ...

After a decade-long search for answers to her difficulties with walking and other physical activities, Joanne Dalessandro of ...

Proposed cuts to the National Institutes of Health and the National Science Foundation “would cause immense and largely ...

Market 32 and Price Chopper have announced the launch of an in-store fundraising campaign to support the Muscular Dystrophy ...

Muscular Dystrophy UK, the leading charity for more than 110,000 children and adults in the UK living with one of over 60 ...

Sarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular dystrophy.

Taiho-developed TAS-205 is designed to selectively inhibit hematopoietic prostaglandin D synthase (HPGDS), an enzyme related ...

WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.

In an announcement by the National Institute for Health and Care Excellence (NICE) it confirms that Zilucoplan (Zilbrysq) ...

Market 32 and Price Chopper have announced the launch of an in-store fundraising campaign to support the Muscular Dystrophy ...